- Clinical Trials
- April 2024
- 200 Pages
Global
From €2410EUR$2,500USD£2,061GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1928EUR$2,000USD£1,649GBP
- Report
- November 2023
- 154 Pages
Global
From €2410EUR$2,500USD£2,061GBP
- Clinical Trials
- April 2024
- 120 Pages
Global
From €1928EUR$2,000USD£1,649GBP
- Clinical Trials
- April 2024
- 180 Pages
Global
From €2410EUR$2,500USD£2,061GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1205EUR$1,250USD£1,031GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4772EUR$4,950USD£4,081GBP
- Report
- January 2022
- 60 Pages
Global
From €3808EUR$3,950USD£3,257GBP
- Report
- January 2022
- 60 Pages
Global
From €3808EUR$3,950USD£3,257GBP
- Report
- January 2022
- 60 Pages
Global
From €3808EUR$3,950USD£3,257GBP
- Report
- January 2022
- 200 Pages
Global
From €7231EUR$7,500USD£6,184GBP
- Report
- January 2022
- 200 Pages
Global
From €7231EUR$7,500USD£6,184GBP
- Report
- January 2022
- 200 Pages
Global
From €7231EUR$7,500USD£6,184GBP
- Report
- January 2022
- 200 Pages
Global
From €7231EUR$7,500USD£6,184GBP
- Report
- August 2022
United States
From €1870EUR$1,940USD£1,600GBP
- Report
- August 2022
United States
From €1870EUR$1,940USD£1,600GBP
- Report
- August 2022
Global
From €762EUR$790USD£651GBP
- Report
- August 2022
Global
From €762EUR$790USD£651GBP
- Report
- August 2021
Europe
From €3297EUR$3,420USD£2,820GBP
- Report
- August 2021
Global
From €3847EUR$3,990USD£3,290GBP
Cirrhosis is a serious liver disorder caused by long-term damage to the liver. It is characterized by scarring of the liver tissue, which can lead to liver failure. Treatment for cirrhosis typically involves medications to reduce inflammation, improve liver function, and reduce the risk of complications. Drugs used to treat cirrhosis include diuretics, antibiotics, antivirals, and immunosuppressants.
The cirrhosis drug market is a subset of the larger liver and kidney disorders drugs market. It is composed of drugs used to treat cirrhosis and its associated complications. These drugs are used to reduce inflammation, improve liver function, and reduce the risk of complications.
Some companies in the cirrhosis drug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more